Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Loading...
Community
/
New Zealand
/
Healthcare
/
Ryman Healthcare
RYM
Ryman Healthcare
Rising Interest Rates And Policy Risks Will Hamper Aged Care
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
22 Aug 25
Updated
22 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
NZ$2.51
0.8% undervalued
intrinsic discount
22 Aug
NZ$2.49
1Y
-49.8%
7D
3.3%
Loading
1Y
-49.8%
7D
3.3%
Author's Valuation
NZ$2.5
0.8% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
NZ$2.5
0.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-437m
914m
2014
2017
2020
2023
2025
2026
2028
Revenue NZ$914.5m
Earnings NZ$487.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
7.10%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.93%
Calculation
NZ$487.86m
Earnings '28
x
7.81x
PE Ratio '28
=
NZ$3.81b
Market Cap '28
NZ$3.81b
Market Cap '28
/
1.24b
No. shares '28
=
NZ$3.07
Share Price '28
NZ$3.07
Share Price '28
Discounted to 2025 @ 6.93% p.a.
=
NZ$2.51
Fair Value '25
